Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
1.910
+0.020 (1.06%)
At close: Mar 28, 2025, 4:00 PM
1.904
-0.006 (-0.29%)
After-hours: Mar 28, 2025, 6:00 PM EDT
Vigil Neuroscience Employees
Vigil Neuroscience had 69 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
69
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,221,101
Market Cap
89.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69 | 0 | - |
| Dec 31, 2023 | 69 | 13 | 23.21% |
| Dec 31, 2022 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VIGL News
- 17 days ago - Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates - GlobeNewsWire
- 19 days ago - Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - GlobeNewsWire
- 2 months ago - Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 2 months ago - Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3 - Benzinga
- 2 months ago - Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer's Disease - GlobeNewsWire
- 2 months ago - Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones - GlobeNewsWire
- 6 months ago - Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927 - GlobeNewsWire
- 6 months ago - Vigil Neuroscience to Present at Cantor Global Healthcare Conference - GlobeNewsWire